Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,750 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial.
Shinohara Y, Katayama Y, Uchiyama S, Yamaguchi T, Handa S, Matsuoka K, Ohashi Y, Tanahashi N, Yamamoto H, Genka C, Kitagawa Y, Kusuoka H, Nishimaru K, Tsushima M, Koretsune Y, Sawada T, Hamada C; CSPS 2 group. Shinohara Y, et al. Among authors: katayama y. Lancet Neurol. 2010 Oct;9(10):959-68. doi: 10.1016/S1474-4422(10)70198-8. Epub 2010 Sep 15. Lancet Neurol. 2010. PMID: 20833591 Clinical Trial.
Benefit of cilostazol in patients with high risk of bleeding: subanalysis of cilostazol stroke prevention study 2.
Uchiyama S, Shinohara Y, Katayama Y, Yamaguchi T, Handa S, Matsuoka K, Ohashi Y, Tanahashi N, Yamamoto H, Genka C, Kitagawa Y, Kusuoka H, Nishimaru K, Tsushima M, Koretsune Y, Sawada T, Hamada C. Uchiyama S, et al. Among authors: katayama y. Cerebrovasc Dis. 2014;37(4):296-303. doi: 10.1159/000360811. Epub 2014 May 8. Cerebrovasc Dis. 2014. PMID: 24820203 Free article.
I. Stroke in general.
Shinohara Y, Yanagihara T, Abe K, Yoshimine T, Fujinaka T, Chuma T, Ochi F, Nagayama M, Ogawa A, Suzuki N, Katayama Y, Kimura A, Kobayashi S. Shinohara Y, et al. Among authors: katayama y. J Stroke Cerebrovasc Dis. 2011 Jul-Aug;20(4 Suppl):S7-30. doi: 10.1016/j.jstrokecerebrovasdis.2011.05.003. J Stroke Cerebrovasc Dis. 2011. PMID: 21835357 Review. No abstract available.
V. Asymptomatic cerebrovascular diseases.
Shinohara Y, Yanagihara T, Abe K, Yoshimine T, Fujinaka T, Chuma T, Ochi F, Nagayama M, Ogawa A, Suzuki N, Katayama Y, Kimura A, Kayama T. Shinohara Y, et al. Among authors: katayama y. J Stroke Cerebrovasc Dis. 2011 Jul-Aug;20(4 Suppl):S116-28. doi: 10.1016/j.jstrokecerebrovasdis.2011.05.012. J Stroke Cerebrovasc Dis. 2011. PMID: 21835353 Review. No abstract available.
II. Cerebral infarction/transient ischemic attack (TIA).
Shinohara Y, Yanagihara T, Abe K, Yoshimine T, Fujinaka T, Chuma T, Ochi F, Nagayama M, Ogawa A, Suzuki N, Katayama Y, Kimura A, Minematsu K. Shinohara Y, et al. Among authors: katayama y. J Stroke Cerebrovasc Dis. 2011 Jul-Aug;20(4 Suppl):S31-73. doi: 10.1016/j.jstrokecerebrovasdis.2011.05.004. J Stroke Cerebrovasc Dis. 2011. PMID: 21835356 Review. No abstract available.
III. Intracerebral hemorrhage.
Shinohara Y, Yanagihara T, Abe K, Yoshimine T, Fujinaka T, Chuma T, Ochi F, Nagayama M, Ogawa A, Suzuki N, Katayama Y, Kimura A, Yasui N. Shinohara Y, et al. Among authors: katayama y. J Stroke Cerebrovasc Dis. 2011 Jul-Aug;20(4 Suppl):S74-99. doi: 10.1016/j.jstrokecerebrovasdis.2011.05.005. J Stroke Cerebrovasc Dis. 2011. PMID: 21835358 Review. No abstract available.
Guidelines for the intravenous application of recombinant tissue-type plasminogen activator (alteplase), the second edition, October 2012: a guideline from the Japan Stroke Society.
Minematsu K, Toyoda K, Hirano T, Kimura K, Kondo R, Mori E, Nakagawara J, Sakai N, Shiokawa Y, Tanahashi N, Yasaka M, Katayama Y, Miyamoto S, Ogawa A, Sasaki M, Suga S, Yamaguchi T; Japan Stroke Society. Minematsu K, et al. Among authors: katayama y. J Stroke Cerebrovasc Dis. 2013 Jul;22(5):571-600. doi: 10.1016/j.jstrokecerebrovasdis.2013.04.001. Epub 2013 May 31. J Stroke Cerebrovasc Dis. 2013. PMID: 23727456 Review.
VII. Rehabilitation.
Shinohara Y, Yanagihara T, Abe K, Yoshimine T, Fujinaka T, Chuma T, Ochi F, Nagayama M, Ogawa A, Suzuki N, Katayama Y, Kimura A, Liu M, Eto F. Shinohara Y, et al. Among authors: katayama y. J Stroke Cerebrovasc Dis. 2011 Jul-Aug;20(4 Suppl):S145-80. doi: 10.1016/j.jstrokecerebrovasdis.2011.05.014. J Stroke Cerebrovasc Dis. 2011. PMID: 21835355 Review. No abstract available.
IV. Subarachnoid hemorrhage.
Shinohara Y, Yanagihara T, Abe K, Fujinaka T, Chuma T, Ochi F, Nagayama M, Ogawa A, Suzuki N, Katayama Y, Kimura A, Yoshimine T. Shinohara Y, et al. Among authors: katayama y. J Stroke Cerebrovasc Dis. 2011 Jul-Aug;20(4 Suppl):S100-15. doi: 10.1016/j.jstrokecerebrovasdis.2011.05.011. J Stroke Cerebrovasc Dis. 2011. PMID: 21835352 Review. No abstract available.
VI. Other types of cerebrovascular disorders.
Shinohara Y, Yanagihara T, Abe K, Yoshimine T, Fujinaka T, Chuma T, Ochi F, Nagayama M, Ogawa A, Suzuki N, Katayama Y, Kimura A, Naritomi H. Shinohara Y, et al. Among authors: katayama y. J Stroke Cerebrovasc Dis. 2011 Jul-Aug;20(4 Suppl):S129-44. doi: 10.1016/j.jstrokecerebrovasdis.2011.05.013. J Stroke Cerebrovasc Dis. 2011. PMID: 21835354 Review. No abstract available.
2,750 results